Pharma Journalist -

Cofactor Genomics declared the results from a study undertaken by them and Fred Hutchinson Cancer Research Center slated for presentation at the Molecular Medicine Tri-Conference in…
Read More...

The network of independent health systems based out of Arkansas, Missouri and Texas collaborate with Vizient for comprehensive sourcing, improvement of performance as well as services…
Read More...

Clearbridge Biomedics announced successful registration of ClearCell® FX1 system, its target cell- enrichment device with the U.S FDA as a class I Medical device for to diagnose…
Read More...

Cepheid declared that clearance has been granted by US FDA 510 (K) waiving clinical laboratory improvement Amendments CLIA for Xpert Xpress Flu test. Performed in near-patient settings,…
Read More...

GT Biopharma announces the successful completion of dosing in its phase 1 clinical trial for GTP-004 that claims to treat Myasthenia gravis. GTP-004 ensures safe administration of…
Read More...

Global standard platform for genomic data, Wuxi NextCode announced partnering with Rhythm to develop and commercialize therapies aimed to treat rare genetic disorders of obesity. Rhythm…
Read More...

Emotional Brain finally declares the successful Phase 2B results for its products Lybrido and Lybridos that were tested in 497 women suffering from Female sexual interest and Arousal…
Read More...

It is to be taken into account that Aerin Medical has been granted clearance for its novel non-invasive Airway Remodeling System termed as VIVAER to overcome nasal airway barriers thus…
Read More...

NovoNordisk pilots an education and disposal program for Californian patients to purge sharp products to safely use the company’s medicines that are otherwise delivered by a syringe or…
Read More...

ESN group committed to natural skin care initiatives announced the rollout of its Ceramedx® brand of natural ceramide therapy products as a substitute for dry and sensitive skin. Earth…
Read More...